November 3, Chengdu Biomedicine Industry Fair held grand
Author:管理员  Addtime:2022-11-05

On November 3,2022, the 5th Congress of cell biology industry and the 3rd China Congress of Biomedicine Innovation and Business Conference of Chengdu Biomedicine industry were held in Chengdu Frontier Medical Center

image.png


The conference is co-hosted by Chengdu high-tech Medical Association, Chengdu High Investment Bio-pharmaceutical Park Management Co. , Ltd. . Guangzhou Zhenghe Exhibition Service Co. , Ltd. . Chengdu Zhixing Medical Culture Media Co. , Ltd. . The conference is a combination of online and offline for 19 investment institutions to participate in the conference, more than 40 investment institutions attended the meeting online, 11 leading enterprises in the biomedical industry, more than 5000 people watched the meeting online, sharing the latest information on the development of the industry.

一、Guest speech

image.png


image.png

image.png

image.png


image.png

二、Project sharing


The meeting invited seven leading companies in the biopharmaceutical industry, including Askeli, Haizhiyuan, Huitai, Wijin, Boattec, Changrui and Beijing penoda, to conduct roadshows for their projects, sharing the latest information, policy developments and industry trends on stem cells, AI medical devices, exosomes, gene therapy, innovative drug R & D and filing, etc. , the latest technologies, products and services of the industry are displayed, and the bio-pharmaceutical industry is discussed and exchanged in depth.

image.png

image.png

image.png

image.png

image.png

image.png

The successful convening of this meeting will further strengthen the confidence and determination of the Chengdu high-tech Medical Association to promote the drive of medical innovation and the integration of medical workers, and help the high-quality coordinated development of the regional bio-pharmaceutical industry, to do a good job in serving the entire industry chain of high-tech and biomedical research and development, and to lead and motivate the biomedical engineering science and technology workers to keep up with the times pace of biomedical development, we will accelerate the transformation of scientific and technological achievements in the bio-pharmaceutical industry.

三、 The investment institution participating on the spot

image.png